Literature DB >> 32881018

Presentation of fatal stroke due to SARS-CoV-2 and dengue virus coinfection.

Cassia F Estofolete1,2, Luana F Machado2, Nathalia Zini1, Graziela D Luckemeyer2, Marilia M Moraes1, Thaysa M I L Dos Santos1, Bárbara F Dos Santos2, Leonardo G P Ruiz2, Nikos Vasilakis3,4,5,6, Suzana M A Lobo2, Mauricio L Nogueira1,2.   

Abstract

Herein, we report a case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and dengue coinfection, presented as a fatal stroke in our hospital, in São José do Rio Preto, São Paulo State, a Brazilian city hyperendemic for dengue viruses and other arthropod-borne viruses (arboviruses) and currently facing a surge of SARS-CoV-2 cases. This case is the first described in the literature and contributes to the better understanding of clinical presentations of two important diseases in a tropical setting.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  COVID-19; arbovirosis; coinfection; dengue; stroke

Year:  2020        PMID： 32881018     DOI： 10.1002/jmv.26476

Source DB:  PubMed          Journal:  J Med Virol        ISSN： 0146-6615            Impact factor:   2.327


  8 in total

1.  Vector-Borne Diseases amidst COVID-19 Pandemic in India - A Mini-Review.

Authors:  K Ariyanachi; Jyothi Tadi Lakshmi; Nikhat Shalam Shireen; Meena S Vidya; Garapati Supriya; Mallamgunta Saranya; S Triveni Sagar; Kesavulu Chenna
Journal:  Maedica (Bucur)       Date:  2022-03

2.  Contact System Activation in Plasma from Dengue Patients Might Harness Endothelial Virus Replication through the Signaling of Bradykinin Receptors.

Authors:  Sharton V A Coelho; Naiara M Rust; Lucas Vellasco; Michelle P Papa; Aline S G Pereira; Matheus Ferreira da Silva Palazzo; Maria Aparecida Juliano; Simone M Costa; Ada M B Alves; Marli T Cordeiro; Ernesto T A Marques; Júlio Scharfstein; Luciana B de Arruda
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-12

3.  Major acute cardiovascular events after dengue infection-A population-based observational study.

Authors:  Kai-Che Wei; Cheng-Len Sy; Wen-Hwa Wang; Chia-Ling Wu; Shang-Hung Chang; Yu-Tung Huang
Journal:  PLoS Negl Trop Dis       Date:  2022-02-07

4.  Clinical and laboratory characteristics of dengue and COVID-19 coinfected patients in Dhaka, Bangladesh.

Authors:  Tabiha Binte Hannan; Zazeba Hossain; Md Nazmul Hasan; Abed Hussain Khan; Md Rafiqul Alam; Md Mujibur Rahman; Shohael Mahmud Arafat; Fazle Rabbi Chowdhury
Journal:  Trans R Soc Trop Med Hyg       Date:  2022-04-20       Impact factor: 2.455

Review 5.  Does dengue and COVID-19 co-infection have worse outcomes? A systematic review of current evidence.

Authors:  Amr Ehab El-Qushayri; Ahmed Mostafa Ahmed Kamel; Abdullah Reda; Sherief Ghozy
Journal:  Rev Med Virol       Date:  2022-02-25       Impact factor: 11.043

6.  Clinical and biochemical parameters of COVID-19 patients with prior or active dengue fever.

Authors:  Isabella Márcia Soares Nogueira Teotônio; Juliana Lott de Carvalho; Luiz Cláudio Castro; Nadjar Nitz; Luciana Hagström; Geraldo Gonçalves Rios; Maria de Fátima Rodrigues de Oliveira; Bruno Stéfano Lima Dallago; Mariana Hecht
Journal:  Acta Trop       Date:  2020-11-28       Impact factor: 3.222

Review 7.  COVID-19, Chikungunya, Dengue and Zika Diseases: An Analytical Platform Based on MALDI-TOF MS, IR Spectroscopy and RT-qPCR for Accurate Diagnosis and Accelerate Epidemics Control.

Authors:  Jéssica Costa; Eugénio C Ferreira; Cledir Santos
Journal:  Microorganisms       Date:  2021-03-30

8.  Clinical features and outcomes of COVID-19 and dengue co-infection: a systematic review.

Authors:  Tsheten Tsheten; Archie C A Clements; Darren J Gray; Ripon K Adhikary; Kinley Wangdi
Journal:  BMC Infect Dis       Date:  2021-08-02       Impact factor: 3.090
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.